ReviewVaccines2024

Respiratory Syncytial Virus Vaccines: Analysis of Pre-Marketing Clinical Trials for Immunogenicity in the Population over 50 Years of Age.

Georgios Papazisis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.